How to buy ResMed (RMD) shares in the UK

Learn how to easily invest in ResMed shares.

ResMed
NYSE: RMD - USD
$218.46
- $0.29 ( - 0.13%)
MEDICAL INSTRUMENTS & SUPPLIES

ResMed Inc (RMD) is a publicly traded medical instruments and supplies business based in the US. It opened the day at $249.93 after a previous close of $250.73. During the day the price has varied from a low of $245.66 to a high of $249.88. The latest price was $247.68 (25 minute delay). ResMed is listed on the NYSE and employs 8,160 staff. All prices are listed in US Dollars.

How to buy shares in ResMed

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: RMD in this case.
  5. Research ResMed shares. The platform should provide the latest information available.
  6. Buy your ResMed shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 5x ResMed shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £5.54
£1,112.91 total
Capital at risk
IG Share Dealing logo £0 £250 £14.52
£1,121.90 total
Capital at risk
Fineco logo £0 No minimum £11.07
£1,118.45 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £23.02
£1,130.40 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.11
£1,108.48 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £24.60
£1,131.98 total
Capital at risk
Stake logo £0 £50 £5.54
£1,112.91 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £23.34
£1,130.72 total
Capital at risk

Full comparison of share dealing platforms

ResMed share price (NYSE:RMD)

Use our graph to track the performance of RMD stocks over time.

ResMed price performance over time

Historical closes compared with the last close of $247.68

1 week (2022-09-23) 15.46%
1 month (2022-08-30) 12.87%
3 months (2022-06-30) 18.15%
6 months (2022-03-29) 0.19%
1 year (2021-09-27) -8.44%
2 years (2020-09-30) 44.48%
3 years (2019-09-30) 83.32%
5 years (2017-09-29) 221.83%

Is it a good time to buy ResMed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

Promoted
eToro Free Stocks

Invest in ResMed shares with 0% commission

  • Start investing from as little as $10
  • Pay no stamp duty on UK shares
  • Join 25 million users who trust their investments with eToro
Other fees apply. Capital at risk

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is ResMed under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

ResMed's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 40x. In other words, ResMed shares trade at around 40x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

PEG ratio

ResMed's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9182. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ResMed's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

EBITDA

ResMed's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $1.1 billion (£1 billion).

The EBITDA is a measure of a ResMed's overall financial performance and is widely used to measure a its profitability.

Environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like ResMed.

Total ESG risk score

ResMed's total ESG risk: 29.05

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and ResMed's overall score of 29.05 (as at 01/01/2019) is nothing to write home about – landing it in it in the 50th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like ResMed is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Environmental score

ResMed's environmental score: 7.42/100

ResMed's environmental score of 7.42 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that ResMed is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Social score

ResMed's social score: 14/100

ResMed's social score of 14 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that ResMed is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Governance score

ResMed's governance score: 12.64/100

ResMed's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that ResMed is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Controversy score

ResMed's controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, ResMed scored a 1 out of 5 for controversy – the highest score possible, reflecting that ResMed has managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

ResMed Inc was last rated for ESG on: 2019-01-01.

Total ESG score 29.05
Total ESG percentile 50.28
Environmental score 7.42
Environmental score percentile 4
Social score 14
Social score percentile 4
Governance score 12.64
Governance score percentile 4
Level of controversy 1

ResMed shares at a glance

Information last updated 2021-07-09.
Open$249.93
High$249.88
Low$245.66
Close$247.68
Previous close$250.73
Change$-3.05
Change %-1.2164%
Volume623,353
Information last updated 2022-09-25.
52-week range$189.047 - $275.6345
50-day moving average$230.4764
200-day moving average$230.4493
Wall St. target price$253.33
PE ratio40.4736
Dividend yield$1.68 (0.81%)
Earnings per share (TTM)$5.3

Do ResMed shares pay dividends?

0.8%

Dividend yield: 0.81% of stock value

0.8%

Forward annual dividend yield: 0.81% of stock value

29.4%

Dividend payout ratio: 29.36% of net profits

ResMed has recently paid out dividends equivalent to 0.81% of its share value annually.

ResMed has paid out, on average, around 29.36% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.81% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 0.81% return on their shares, in the form of dividend payments. In ResMed's case, that would currently equate to about $1.68 per share.

While ResMed's payout ratio might seem fairly standard, it's worth remembering that it may be investing much of the rest of its net profits in future growth.

ResMed's most recent dividend payout was on 22 September 2022. The latest dividend was paid out to all shareholders who bought their shares by 17 August 2022 (the "ex-dividend date").

Share price volatility

Over the last 12 months, ResMed's shares have ranged in value from as little as $189.047 up to $275.6345. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while ResMed's is 0.4974. This would suggest that ResMed's shares are less volatile than average (for this exchange).

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site